Interim Report Q3 – January – September, 2023 Redsense Medical AB (publ)
JULY – SEPTEMBER 2023 · Net sales amounted to kSEK 5,287 (1,023), an increase of 417%. · Operating loss, EBIT amounted to kSEK 959 (5,857). · Result after tax amounted to kSEK -1,008 (-2,372). · Earnings per share were SEK -0.07 (-0.17). SIGNIFICANT EVENTS DURING THE PERIOD · On July 7, Redsense alarm system was featured in KFF Health News · On August 15, Redsense secured a strong autumn with a mSEK 11.2 order. · On September 27, Redsense Medical arranged Congressional Briefing to address Venous Needle Dislodgement. · On September 28, Redsense announced that